C-X-C Chemokines and Kaposi's Sarcoma
C-X-C Chemokines and Kaposi's Sarcoma
批准号:
6346724
负责人:
David Michael Markovitz
金额:
$30.23万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) The chemokines are small, chemo-attractant
molecules which are a part of the cytokine family. The two major groups of
chemokines are the C-X-C and C-C chemokines and the receptors for specific
C-X-C and C-C chemokines have been shown to be important coreceptors for HIV-1
and HIV-2. We have now demonstrated that infection of monocytic cells by HIV-1
leads to the elaboration of substantially increased amounts of the C-X-C
chemokines interleukin-8 (IL-8) and growth-related oncogene a (GRO-a). We have
also shown that the increased production of GRO-a is mediated by interaction of
the viral gpl2O with CXCR4 and stimulation of LL-8 is mediated by gp120 and the
viral transactivating protein Tat. Both IL-8 and GRO-a then stimulate HIV-1
replication in monocytic cells and T cells, thus completing an autocrine loop
which would favor HIV-l replication.
GRO-cx and IL-8 are angiogenic chemokines, which have also recently been shown
to stimulate signaling through the Kaposi's Sarcoma Herpesvirus (KSHV)-encoded
G protein coupled receptor. Our group has now demonstrated that GRO-a and IL-8
are produced by KSHV-infected human endothelial cells, and are major mediators
of angiogenesis in vitro and in a mouse model. Therefore, our hypothesis is
that KSHV infection of endothelial cells, and HIV-1 infection of adjacent
monocytic cells, leads to substantial increases in the level of the C-X-C
chemokines GRO-a and IL-8, promoting angiogenesis and the development of KS.
In view of the above, we now propose to further characterize the role of IL-8
and GRO-a in the replication of KSHV and in the transformation and angiogenic
potential of KSHV-infected endothelial cells. In addition, using quantitative
image single cell analysis, we will examine whether changes in the levels of
IL-8 and/or GRO-a expression are associated with KSHV replication and/or
morphologic patterns in KS lesions from patients. Further, we will investigate
whether blocking these chemokines or their receptors will affect KSHV
replication and/or interfere with the angiogenic response or endothelial cell
transformation. This work thus has the potential to link KSHV, growth factors,
and HIV/Tat in the pathogenesis of KS, and to suggest new avenues for the
treatment of this complex neoplasm.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses
-
批准号:10629566
-
项目类别:
-
资助金额:$72.82万
-
财政年份:2023
-
负责人:David Michael Markovitz
-
依托单位:
DEK and TNF inhibitors in juvenile arthritis
-
批准号:8311059
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
Replication of Human Endogenous Retroviruses in Modern Humans
-
批准号:8318290
-
项目类别:
-
资助金额:$123.18万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
Replication of Human Endogenous Retroviruses in Modern Humans
-
批准号:7762721
-
项目类别:
-
资助金额:$143.53万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
DEK and TNF inhibitors in juvenile arthritis
-
批准号:8130630
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
DEK and TNF inhibitors in juvenile arthritis
-
批准号:7835950
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
DEK and TNF inhibitors in juvenile arthritis
-
批准号:7938774
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
Replication of Human Endogenous Retroviruses in Modern Humans
-
批准号:8119694
-
项目类别:
-
资助金额:$124.02万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
Replication of Human Endogenous Retroviruses in Modern Humans
-
批准号:8550159
-
项目类别:
-
资助金额:$8.26万
-
财政年份:2009
-
负责人:David Michael Markovitz
-
依托单位:
CXC Chemokines and HIV Pathogenesis
-
批准号:7160544
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2005
-
负责人:David Michael Markovitz
-
依托单位:
CXC Chemokines and HIV Pathogenesis
-
批准号:6946547
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2005
-
负责人:David Michael Markovitz
-
依托单位:
CXC Chemokines and HIV Pathogenesis
-
批准号:7555925
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2005
-
负责人:David Michael Markovitz
-
依托单位:
CXC Chemokines and HIV Pathogenesis
-
批准号:7332237
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2005
-
负责人:David Michael Markovitz
-
依托单位:
CXC Chemokines and HIV Pathogenesis
-
批准号:7050061
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2005
-
负责人:David Michael Markovitz
-
依托单位:
CXC Chemokines and HIV Pathogenesis
-
批准号:6839891
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2004
-
负责人:David Michael Markovitz
-
依托单位:
C-X-C Chemokines and Kaposi's Sarcoma
-
批准号:6758555
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2001
-
负责人:David Michael Markovitz
-
依托单位:
C-X-C Chemokines and Kaposi's Sarcoma
-
批准号:6908120
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2001
-
负责人:David Michael Markovitz
-
依托单位:
C-X-C Chemokines and Kaposi's Sarcoma
-
批准号:6608129
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2001
-
负责人:David Michael Markovitz
-
依托单位:
C-X-C Chemokines and Kaposi's Sarcoma
-
批准号:6537696
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2001
-
负责人:David Michael Markovitz
-
依托单位:
CELLULAR FACTORS INVOLVED IN HIV GENE EXPRESSION
-
批准号:6274727
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:David Michael Markovitz
-
依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位: